The effects of ECT on brain glucose: A pilot FDG PET study

Journal of ECT

Volumn 17, Issue 1, 2001, Pages 33-40

  Henry, Michael E ^a,b   Schmidt, Mark E ^c   Matochik, John A ^d   Stoddard, Eve P ^a,b   Potter, William Z ^c  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c ELI LILLY AND COMPANY   (United States)

^d NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Brain glucose; Electroconvulsive therapy; 18F fluorodeoxyglucose (FDG) positron emission tomography (PET)

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE;

ADULT; ARTICLE; BASAL GANGLION; BRAIN STEM; CLINICAL ARTICLE; DEPRESSION; ELECTROCONVULSIVE THERAPY; FEMALE; FRONTAL LOBE; GLUCOSE BRAIN LEVEL; GLUCOSE METABOLISM; HUMAN; MALE; METABOLIC RATE; OCCIPITAL LOBE; PARIETAL LOBE; POSITRON EMISSION TOMOGRAPHY;

EID: 0035078785     PISSN: 10950680     EISSN: None     Source Type: Journal    
DOI: 10.1097/00124509-200103000-00007     Document Type: Article

References (29)

1. Treatment-resistant depression
2. Central issues regarding the mechanisms of action of electroconvulsive therapy: Directions for future research
3. Animal studies of electroconvulsive therapy: Foundations for future research
4. The next challenge: The mode of action of ECT
5. Positron emission tomography and autoradiographic studies of glucose utilization following electroconvulsive seizures in humans and rats
6. Regional cerebral blood flow in mood disorders, III: Treatment and clinical response
7. Acute and late effects of electroconvulsive therapy. Clinical outcome, regional cerebral blood flow, and electroencephalogram
8. Effects of electroconvulsive therapy on brain glucose metabolism: A preliminary study
9. Comparisons of conical and subcortical lesions in the production of poststroke mood disorders
10. Frontal lobe dysfunction in secondary depression
11. The neuroanatomy of depression
12. Increased cerebral blood flow in depressed patients responding to electroconvulsive therapy
13. Hypothalamic-pituitary-adrenal axis and monoamine transmitter activity in depression: A pilot study of central and peripheral effects of electroconvulsive therapy
14. Cerebral glucose metabolism during pharmacologic studies: Test-retest under placebo conditions
15. Development of a rating scale for primary depressive illness
16. Behavioral activation and the variability of cerebral glucose metabolic measurements
17. Regional brain glucose metabolism after acute alpha-2 blockade by Idazoxan
18. Tomographic measurement of local cerebral glucose metabolic rate of humans with [18-F] 1-fluoro-2-deoxy-D-glucose: Validation of method
19. Noninvasive determination of local cerebral metabolic rate of glucose in man
20. Acute alpha 2 blockade by idazoxan increases insulin and lowers plasma glucose during positron emission tomography
21. Quantitative Cerebral Anatomy in Depression
22. Cortical abnormalities associated with subcortical lesions in vascular dementia
23. Major depression and the basal ganglia
24. Cerebral metabolic rates for glucose in mood disorders: Studies with positron emission tomography and fluorodeoxyglucose F 18
25. Gender differences in brain metabolic and plasma catecholamine responses to alpha 2-adrenoceptor blockade
26. Regional differences in cerebral blood flow and glucose utilization in diabetic man: The effect of insulin